CareDx, Inc.

CareDx is a precision medicine company focused on improving outcomes for transplant patients and advancing organ health. The company provides integrated solutions designed to empower clinicians and improve patient outcomes. These solutions include non-invasive molecular testing for heart, kidney, and lung transplants, laboratory products, digital health technologies, and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics-based information for transplant patients. The company's headquarters is in Brisbane, California, with other primary operations in Omaha, Nebraska, and Stockholm, Sweden. CareDx was originally incorporated in Delaware in December 1998 as Hippocratic Engineering, Inc., changing its name to BioCardia, Inc. in April 1999, Expression Diagnostics, Inc. in June 2002, XDx, Inc. in July 2007, and finally CareDx, Inc. in March 2014. As of December 31, 2025, substantially all of CareDx's revenues came from the United States and Europe, and substantially all of its assets and operations were located in the United States and Sweden. The company is organized and operates as a single reportable segment.